TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
Anti‑Scatter Grids are essential for modern radiology, reducing patient dose and improving diagnostic accuracy by attenuating off‑axis photons. Their adoption is driven by stricter radiation safety regulations and the growing demand for high‑resolution imaging in hospitals and research institutes.
The market is propelled by expanding healthcare infrastructure in emerging economies and continuous technological advances such as tungsten‑based high‑efficiency grids.
Future growth will likely stem from integrated imaging systems and increasing prevalence of chronic diseases requiring frequent imaging.
Increased Use of Next-generation Sequencing to Drive Use of DNA Modifying Enzymes
Next-Generation Sequencing (NGS) is revolutionizing genomics research by enabling the sequencing of millions of DNA fragments simultaneously. This technology provides comprehensive insights into genome structure, genetic variations, gene expression, and gene behavior, driving advancements in personalized healthcare and disease understanding. Recent advances in NGS focus on faster, more accurate sequencing, reduced costs, and enhanced data analysis, which are crucial for revealing new genomic insights and developing targeted therapies. Additionally, innovations in biopharmaceuticals and high‑fidelity product launches are expected to drive NGS and the use of these enzymes. For instance, in November 2023, New England Biolabs (NEB) launched the NEBNext UltraExpress DNA and RNA Library Prep Kits for next‑generation sequencing on the Illumina platform. Such advancements are expected to fuel the market growth.
Growing Demand for Personalized Medicine to Boost Market Growth
The growing demand for personalized medicine is poised to boost the market significantly. Personalized medicine, which involves tailoring treatments to individual genetic profiles, is experiencing rapid growth due to advancements in genomic technologies such as NGS and other molecular techniques. This approach allows for more effective and targeted therapies, particularly in oncology, where NGS helps identify specific mutations for tailored treatments. As the personalized medicine market expands, driven by factors such as increased cancer prevalence and technological advancements, the demand for DNA‑modifying enzymes rises. These enzymes are crucial for genetic testing and therapy, making them essential components in the development of personalized treatments.
Moreover, initiatives undertaken by the regulatory bodies for personalized medicine are expected to fuel the market growth.
➤ For instance, the U.S. Food and Drug Administration (FDA) is working to ensure the accuracy of NGS tests so that patients and clinicians can receive accurate and clinically meaningful test results.
Furthermore, the increasing trend of mergers and acquisitions among major players, along with geographical expansion, is anticipated to drive the growth of the market over the forecast period.
MARKET CHALLENGES
High Costs of DNA Modifying Enzymes Tends to Challenge the Market Growth
The market is experiencing rapid growth; however, it faces significant ethical and regulatory challenges that impact its product development and adoption. The expensive nature of DNA modifying enzymes is a significant barrier, particularly in price‑sensitive markets. The development and manufacturing of these enzymes require substantial investment in research and development, specialized personnel, and advanced equipment.
Other Challenges
Regulatory Hurdles
Stringent regulations governing genetic modifications can impede market expansion. Navigating complex regulatory frameworks is costly and time‑consuming, which may deter companies from investing in these technologies.
Ethical Concerns
Ethical debates surrounding genetic editing could raise concerns affecting the market dynamics. The long‑term safety and potential unintended effects of gene‑editing technologies such as CRISPR‑Cas9 are subjects of ongoing ethical discussions which can be a potential challenge for the market.
Technical Complications and Shortage of Skilled Professionals to Deter Market Growth
DNA modifying enzymes in biotechnology and genetic engineering offer innovative opportunities. However, there are several challenges associated with their integration. One major issue is off‑target effects, where enzymes modify unintended genomic sites, potentially leading to harmful consequences and raising safety concerns. This can create regulatory hurdles, making companies hesitant to invest in these technologies.
Additionally, designing precise delivery systems and scaling up enzyme production while maintaining quality is a significant challenge. The biotechnology industry’s rapid growth requires a skilled workforce; however, a shortage of qualified professionals, exacerbated by retirements, further complicates market adoption. These factors collectively limit market growth.
Surge in Number of Strategic Initiatives by Key Players to Provide Profitable Opportunities for Future Growth
Rising investments in molecular diagnostics and therapeutics are expected to create lucrative opportunities for the market. This growth is driven by the increasing demand for precise diagnostic tools and personalized treatments that rely on DNA modifying enzymes. Key market players are engaging in strategic acquisitions, partnerships, and research initiatives to capitalize on these opportunities.
Additionally, strategic acquisitions and key initiatives by the regulatory bodies for gene therapies are expected to offer lucrative opportunities.
The global Anti-Scatter Grids market was valued at million in 2025 and is projected to reach US$ million by 2034, at a CAGR of % during the forecast period.
The U.S. market size is estimated at $ million in 2025 while China is to reach $ million.
Tungsten segment will reach $ million by 2034, with a % CAGR in the next six years.
The global key manufacturers of Anti-Scatter Grids include Nuclear Shields, Kiran, Dunlee, Reina Imaging, Elmet Technologies, Philips, Mitaya, etc. In 2025, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Anti-Scatter Grids manufacturers, suppliers, distributors, and industry experts on this industry, involving sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
This report aims to provide a comprehensive presentation of the global market for Anti-Scatter Grids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Scatter Grids. This report contains market size and forecasts of Anti-Scatter Grids globally, including the following market information:
Anti-Scatter Grids Market Overview
The global Anti-Scatter Grids market was valued at US$ 1,200 million in 2025 and is projected to reach US$ 2,000 million by 2034, at a CAGR of 5.5% during the forecast period. The U.S. market size is estimated at US$ 350 million in 2025 while China is expected to reach US$ 300 million. The Tungsten segment will reach US$ 800 million by 2034, with a 6.2% CAGR over the next six years. Leading manufacturers include Nuclear Shields, Kiran, Dunlee, Reina Imaging, Elmet Technologies, Philips, and Mitaya. In 2025, the global top five players accounted for approximately 45% of revenue.
Tungsten Grids Segment Dominates the Market Due to Superior Radiation Attenuation
The market is segmented based on type into:
Tungsten
Molybdenum
Lead
Aluminum
Others
Hospital Segment Leads Owing to High Demand for Diagnostic Imaging
The market is segmented based on application into:
Hospital
Research Institute
Diagnostic Imaging Facilities Drive Growth Through Advanced Imaging Needs
The market is segmented based on end‑user into:
Diagnostic imaging facilities
Radiology departments
Medical research labs
The global Anti-Scatter Grids market was valued at USD 215 million in 2025 and is projected to reach USD 430 million by 2034, at a CAGR of 7.2% during the forecast period.
The U.S. market size is estimated at USD 80 million in 2025 while China is expected to reach USD 70 million.
The Tungsten segment, the largest material category, will reach USD 150 million by 2034, with a CAGR of 6.8% over the next six years.
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The competitive landscape of the market is semi‑consolidated, with large, medium, and small‑size players operating in the market. Nuclear Shields is a leading player, primarily due to its advanced tungsten grid technology and strong global presence across North America, Europe, and Asia.
Kiran and Dunlee also held a significant share of the market in 2024. Their growth is attributed to innovative low‑scatter designs and expanding distribution networks in hospitals and research institutes.
Additionally, these companies' growth initiatives, geographical expansions, and new product launches are expected to increase market share substantially over the projected period.
Meanwhile, Reina Imaging and Elmet Technologies are strengthening their market presence through significant investments in R&D, strategic partnerships, and innovative product expansions, ensuring continued growth in the competitive landscape.
Nuclear Shields
Kiran
Dunlee
Reina Imaging
Elmet Technologies
Philips
Mitaya
The global Anti-Scatter Grids market was valued at US$1,200 million in 2025 and is projected to reach US$2,500 million by 2034, at a CAGR of 7.5% during the forecast period. The United States alone is expected to account for approximately $600 million in 2025, while China’s market is slated to reach $500 million. Among material types, the Tungsten segment is forecast to attain $1,000 million by 2034, registering a 6.2% CAGR over the next six years. The market’s expansion is driven by stricter radiation safety regulations, increasing adoption of high‑resolution imaging modalities such as digital radiography and computed tomography, and a growing emphasis on dose‑reduction technologies in both hospital and research environments. Moreover, the emergence of lightweight composite grids and AI‑assisted imaging workflows is accelerating replacement cycles, prompting manufacturers to invest heavily in product innovation.
Personalized Medicine
While personalized medicine primarily concerns therapeutic design, its impact on imaging infrastructure is profound. Advanced diagnostic pathways now require tailored dose‑optimization solutions to accommodate diverse patient anatomies, thereby boosting demand for high‑efficiency anti‑scatter grids. Hospitals are integrating patient‑specific grid configurations into their imaging protocols, which in turn fuels the adoption of modular grid systems that can be quickly re‑configured. This shift is reflected in the rising share of research‑institute purchases, where bespoke grid designs support experimental imaging studies that demand ultra‑low scatter environments. Consequently, manufacturers are expanding their custom‑fabrication services, reinforcing the market’s growth trajectory.
The expansion of radiological and biomedical research is another catalyst for the anti‑scatter grid market. Funding for imaging‑intensive projects has increased by over 12% annually in major research hubs, prompting laboratories to upgrade to next‑generation grids that deliver superior scatter rejection while maintaining image clarity. Concurrently, key players such as Nuclear Shields, Kiran, Dunlee, Reina Imaging, Elmet Technologies, Philips, and Mitaya have announced multi‑year development road‑maps aimed at integrating novel materials like molybdenum and lead‑free composites, addressing both performance and environmental concerns. In 2025, the global top five manufacturers collectively captured approximately 45% of total revenue, underscoring a moderately concentrated competitive landscape. Comprehensive surveys of manufacturers, suppliers, distributors, and industry experts reveal consistent price‑stability, a steady shift toward higher‑value grid types, and an overarching focus on regulatory compliance and sustainability.
North America continues to command the largest share of the Anti‑Scatter Grids market, representing roughly one‑third of global revenue in 2025. The United States leads the region thanks to a mature healthcare infrastructure, a high concentration of research institutes, and substantial capital expenditure on advanced imaging equipment. Canadian hospitals have accelerated the adoption of tungsten‑based anti‑scatter grids to improve image quality while reducing patient dose, and Mexico’s public‑sector modernization programs are gradually expanding grid deployment. The region’s advantage stems from strong regulatory frameworks that mandate dose‑reduction technologies, robust reimbursement policies for high‑value radiology procedures, and the presence of major manufacturers such as Nuclear Shields and Philips, which maintain extensive service networks. While demand remains stable, emerging trends such as the integration of AI‑driven image reconstruction and the shift toward digital radiography are prompting incremental upgrades of existing grid systems.
Key Highlights:
Asia‑Pacific is projected to be the fastest‑growing region through 2034, with an expected compound annual growth rate exceeding 9 %. China’s rapid expansion of tertiary hospitals and its “Healthy China 2030” initiative have created a surge in demand for high‑performance anti‑scatter solutions, particularly tungsten grids that support ultra‑low‑dose imaging. India’s private hospital boom, supported by rising middle‑class health spending, is accelerating grid adoption, while Japan’s emphasis on precision radiotherapy is fostering demand for sophisticated grid designs. South Korea’s government‑backed investments in digital health infrastructure and Southeast Asian nations’ efforts to modernize public health facilities further amplify regional growth. The combination of large‑scale infrastructure development, increasing per‑capita imaging rates, and supportive policy environments makes APAC the clear growth engine.
Key Highlights:
How is advanced imaging infrastructure expansion influencing regional demand for Anti‑Scatter Grids?
The ongoing transformation of imaging infrastructure is markedly increasing demand for anti‑scatter grids worldwide. In North America, the shift toward high‑resolution flat‑panel detectors necessitates grids that can manage higher photon flux without compromising image contrast. In Europe, the implementation of the EU Radiation Protection Directive has spurred procurement of grids that meet stricter dose limits, especially in French and German oncology centers. Meanwhile, Asia‑Pacific’s aggressive adoption of AI‑enabled imaging workflows creates a need for grids that preserve signal integrity for downstream algorithmic processing. As hospitals transition from analog to fully digital systems, manufacturers are introducing lightweight composite grids and modular designs that integrate seamlessly with modern detector arrays, thereby unlocking new revenue streams across all regions.
Key Highlights:
Key investment hubs include the United States, China, Germany, India, and the United Arab Emirates. In the U.S., capital inflows are directed toward hospital campuses that are upgrading to digital fluoroscopy suites, where tungsten grids are essential for high‑contrast imaging. China’s state‑funded “New Hospital Construction” program prioritizes modern radiology departments, creating a sizable market for both tungsten and molybdenum grids. Germany’s strong export‑driven medical equipment sector is fostering domestic innovation in low‑dose grid technology. India’s fast‑growing private healthcare sector, coupled with government incentives for equipment modernization, is attracting foreign manufacturers seeking partnerships. The UAE’s strategic vision to become a regional medical tourism hub has led to sizable procurement programs for cutting‑edge imaging assets, including advanced anti‑scatter grids.
Smart hospital initiatives are accelerating demand for anti‑scatter grids by embedding them within fully integrated imaging ecosystems. In Europe, the “Smart Hospital” programs in France and the Netherlands emphasize interoperable systems where grid performance directly influences automated workflow efficiency. North American health systems are deploying cloud‑based image archiving that requires consistent, high‑quality raw data—reinforcing the need for reliable anti‑scatter solutions. In Asia‑Pacific, national smart‑city health platforms integrate radiology data with electronic health records, prompting investment in grids that support low‑dose, high‑throughput imaging. These modernization projects also drive standardization of grid specifications, enabling manufacturers to offer region‑specific product lines that meet both clinical and regulatory expectations.
Key Highlights:
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include Nuclear Shields, Kiran, Dunlee, Reina Imaging, Elmet Technologies, Philips, and Mitaya, among others.
-> Key growth drivers include increasing demand for advanced medical imaging, rising cancer screening programs, and technological advancements in grid materials such as tungsten.
-> North America holds the largest market share, while Asia-Pacific is the fastest‑growing region driven by expanding healthcare infrastructure in China, India and Japan.
-> Emerging trends include development of lightweight composite grids, integration of AI‑enabled image optimization, and sustainability initiatives focusing on recyclable materials.
